Prospects of antigen-specific therapy in type 1 diabetes mellitus

Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatiana Vasil'evna Nikonova, Yulia Viktorovna Alekseeva
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2012
Materias:
Acceso en línea:https://doaj.org/article/dcc7b58ce30f498f8bd52c9a5e94510c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.